A fast-growing, globally active biotech company with strong roots in the rare disease space and a clear focus on immunology and severe autoimmune conditions. The company is dedicated to developing innovative, antibody-based therapies for patients with high unmet medical need, translating cutting-edge science into meaningful treatment options.
What sets the organization apart is its specialization in rare and complex diseases, a highly focused and innovative pipeline, and a strong international presence across Europe, the United States, and Japan. In addition, it combines scientific excellence with a clear ambition to ensure patient access to novel therapies.
The culture is entrepreneurial, collaborative, and purpose-driven, with teams united by curiosity, innovation, and a shared commitment to making a tangible difference in patients’ lives.
Volker Geiße
vg@nik-executivesearch.com
Germany, South